BIOMAT Database Logo BIOMAT Database Logo

Warfarin-stereochemical aspects of its metabolism by rat liver microsomes. 1976

L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.
July 1981, Biochemical pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
October 1976, Research communications in chemical pathology and pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
June 1974, The Journal of clinical investigation,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes.
April 1997, Chemical research in toxicology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Digitoxigenin metabolism by rat liver microsomes and its induction by phenobarbital.
July 1973, Biochemical pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Methaqualone metabolism by rat liver microsomes.
January 1976, Research communications in chemical pathology and pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Digitoxin metabolism by rat liver microsomes.
September 1975, Biochemical pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
The metabolism of imipramine and its metabolites by rat liver microsomes.
August 1966, Biochemical pharmacology,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Metabolism of lofepramine by rat liver microsomes.
February 1982, Xenobiotica; the fate of foreign compounds in biological systems,
L R Pohl, and S D Nelson, and W R Porter, and W F Trager, and M J Fasco, and F D Baker, and J W Fenton
Metabolism of hexachlorobenzene by rat-liver microsomes.
January 1986, IARC scientific publications,
Copied contents to your clipboard!